We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$961M
AUM Growth
+$374M
Cap. Flow
-$4.74M
Cap. Flow %
-0.49%
Top 10 Hldgs %
44.93%
Holding
194
New
69
Increased
29
Reduced
39
Closed
48

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$24.6M
2
AGN
Allergan plc
AGN
+$24.2M
3
MRK icon
Merck
MRK
+$22.3M
4
AMGN icon
Amgen
AMGN
+$17.6M
5
ENDP
Endo International plc
ENDP
+$17.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$33.6M
2
SHPG
Shire pic
SHPG
+$20.7M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$18.2M
4
BIIB icon
Biogen
BIIB
+$11.8M
5
ISRL
Isramco Inc
ISRL
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 53.73%
2 Technology 2.61%
3 Industrials 1.8%
4 Consumer Discretionary 1.51%
5 Utilities 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
– –
-33,966
Closed -$2.88M
CASC
177
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-71,333
Closed -$813K
RXDX
178
DELISTED
Ignyta, Inc.
RXDX
– –
-179,055
Closed -$1.23M
CEMP
179
DELISTED
Cempra, Inc.
CEMP
– –
-100,000
Closed -$2.35M
CKP
180
DELISTED
CHECKPOINT SYSTEMS INC
CKP
– –
-19,688
Closed -$1.55M
ZSPH
181
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-20,682
Closed -$860K
LMNS
182
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$0 ﹤0.01%
+245
New +$2.66K
PCYC
183
DELISTED
PHARMACYCLICS INC
PCYC
– –
-48,840
Closed -$5.97M
SLXP
184
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-158,500
Closed -$18.2M
NPSP
185
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-80,000
Closed -$2.86M
CTIC
186
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-75,000
Closed -$1.77M
KBIO
187
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-43,695
Closed -$605K
ISRL
188
DELISTED
Isramco Inc
ISRL
– –
-64,958,387
Closed -$11.1M
LJPC
189
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-100,230
Closed -$1.85M
RPRX
190
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-100,000
Closed -$997K
GCVRZ
191
DELISTED
Sanofi Contingent Value Rights
GCVRZ
– –
-67,960
Closed -$6.22M
4 5 6 7
8

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2015 Portfolio in Review

As of Q1 2015, Sphera Funds Management held 194 positions worth $961M, up 64% from $587M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sphera Funds Management's Q1 2015 filing shows 69 new, 29 increased, 39 reduced and 48 closed positions. Its largest new stake was AbbVie: 407,000 shares worth $23.8M. The largest sale was Novartis, an estimated $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 63% a quarter earlier, followed by Technology and Industrials.

  • Sphera Funds Management's largest Q1 2015 buy was AbbVie: 407,000 shares worth $23.8M.
  • Sphera Funds Management added most to Allergan plc in Q1 2015, an estimated $24.2M increase.
  • Sphera Funds Management's biggest Q1 2015 reduction was Novartis, cutting an estimated $33.6M.
  • Sphera Funds Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q1 2015, selling an estimated $18.2M.
  • Sphera Funds Management's ten largest holdings make up 45% of its $961M portfolio in Q1 2015.
  • Sphera Funds Management opened 69 new positions and closed 48 in Q1 2015.
  • Sphera Funds Management's portfolio value rose 64% quarter-over-quarter to $961M.

Based on Sphera Funds Management's 13F filing for Q1 2015, filed 11 May 2015.